Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	bone sialoprotein binding	ANXA2 ANXA2P2	6.14e-05	2	157	2	GO:0044730
GeneOntologyBiologicalProcess	social behavior	NLGN4Y CHRNB2 PIANP NLGN4X MTOR HTT	2.29e-05	74	159	6	GO:0035176
GeneOntologyBiologicalProcess	brainstem development	NLGN4Y GART NLGN4X	2.45e-05	8	159	3	GO:0003360
GeneOntologyBiologicalProcess	biological process involved in intraspecies interaction between organisms	NLGN4Y CHRNB2 PIANP NLGN4X MTOR HTT	2.67e-05	76	159	6	GO:0051703
GeneOntologyBiologicalProcess	positive regulation of low-density lipoprotein particle receptor binding	ANXA2 ANXA2P2	5.91e-05	2	159	2	GO:1905597
GeneOntologyCellularComponent	postsynaptic membrane	NAPEPLD NLGN4Y SYNE1 ACTN2 ITGA3 CHRNA3 PCDH17 CHRNB2 SLC6A11 STRN NLGN4X LRFN5 KCTD16 FLRT3 DMD ADGRL2	7.87e-08	405	158	16	GO:0045211
GeneOntologyCellularComponent	synaptic membrane	NAPEPLD NLGN4Y SYNE1 ITSN1 ACTN2 NCSTN ITGA3 CHRNA3 PCDH17 CHRNB2 SLC6A11 STRN NLGN4X LRFN5 KCTD16 FLRT3 DMD ADGRL2 HTT	9.38e-08	583	158	19	GO:0097060
GeneOntologyCellularComponent	postsynapse	DRP2 NAPEPLD ATR NLGN4Y SYNE1 SPTAN1 ITSN1 ACTN2 ITGA3 ZNF804A CHRNA3 PCDH17 CHRNB2 SLC6A11 STRN NLGN4X MTOR LRFN5 KCTD16 FLRT3 DMD ADGRL2 HTT	2.54e-06	1018	158	23	GO:0098794
GeneOntologyCellularComponent	presynapse	DMXL2 ATP6V0A1 NPY5R NAPEPLD ATR NLGN4Y ITSN1 TRPC5 NTS NCSTN ITGA3 ZNF804A PCDH17 CHRNB2 SLC6A11 PIANP NLGN4X KCTD16 FLRT3 DMD HTT	3.47e-06	886	158	21	GO:0098793
GeneOntologyCellularComponent	GABA-ergic synapse	NPY5R ATR NLGN4Y PCDH17 SLC6A11 NLGN4X LRFN5 DMD	3.59e-05	164	158	8	GO:0098982
GeneOntologyCellularComponent	AnxA2-p11 complex	ANXA2 ANXA2P2	1.69e-04	3	158	2	GO:1990665
GeneOntologyCellularComponent	PCSK9-AnxA2 complex	ANXA2 ANXA2P2	1.69e-04	3	158	2	GO:1990667
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4Y NLGN4X	3.37e-04	4	158	2	GO:0098983
GeneOntologyCellularComponent	syntrophin complex	SNTG2 DMD	3.37e-04	4	158	2	GO:0016013
GeneOntologyCellularComponent	sarcolemma	ANXA2 ANXA2P2 NCSTN RYR2 SNTG2 PRKCQ DMD	6.17e-04	190	158	7	GO:0042383
GeneOntologyCellularComponent	axonemal dynein complex	DNAH7 DNAH12 DNAH5	8.62e-04	25	158	3	GO:0005858
GeneOntologyCellularComponent	myelin sheath adaxonal region	ANXA2 ANXA2P2	1.16e-03	7	158	2	GO:0035749
GeneOntologyCellularComponent	presynaptic membrane	NAPEPLD ITSN1 NCSTN ITGA3 PCDH17 CHRNB2 SLC6A11 KCTD16	1.25e-03	277	158	8	GO:0042734
Domain	Spectrin	DRP2 SYNE1 SPTAN1 ACTN2 DMD	1.07e-06	23	154	5	PF00435
Domain	Spectrin_repeat	DRP2 SYNE1 SPTAN1 ACTN2 DMD	3.61e-06	29	154	5	IPR002017
Domain	SPEC	DRP2 SYNE1 SPTAN1 ACTN2 DMD	6.01e-06	32	154	5	SM00150
Domain	Spectrin/alpha-actinin	DRP2 SYNE1 SPTAN1 ACTN2 DMD	6.01e-06	32	154	5	IPR018159
Domain	ACTININ_2	FLNB SYNE1 ACTN2 DMD	3.48e-05	23	154	4	PS00020
Domain	ACTININ_1	FLNB SYNE1 ACTN2 DMD	3.48e-05	23	154	4	PS00019
Domain	Actinin_actin-bd_CS	FLNB SYNE1 ACTN2 DMD	3.48e-05	23	154	4	IPR001589
Domain	SNO	SBNO2 SBNO1	6.75e-05	2	154	2	IPR026741
Domain	SBNO_Helicase_C_dom	SBNO2 SBNO1	6.75e-05	2	154	2	IPR026937
Domain	Dopey_N	DOP1A DOP1B	6.75e-05	2	154	2	PF04118
Domain	NLGN4	NLGN4Y NLGN4X	6.75e-05	2	154	2	IPR030025
Domain	Dopey_N	DOP1A DOP1B	6.75e-05	2	154	2	IPR007249
Domain	Helicase_C_4	SBNO2 SBNO1	6.75e-05	2	154	2	PF13871
Domain	Dynein_heavy_chain_D4_dom	DNAH7 DNAH12 DNAH5	1.87e-04	14	154	3	IPR024317
Domain	Dynein_heavy_dom-2	DNAH7 DNAH12 DNAH5	1.87e-04	14	154	3	IPR013602
Domain	DHC_N2	DNAH7 DNAH12 DNAH5	1.87e-04	14	154	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH12 MDN1 DNAH5	1.87e-04	14	154	3	IPR011704
Domain	AAA_8	DNAH7 DNAH12 DNAH5	1.87e-04	14	154	3	PF12780
Domain	AAA_5	DNAH12 MDN1 DNAH5	1.87e-04	14	154	3	PF07728
Domain	AAA	ABCA4 DNAH7 ABCC6 DNAH12 MDN1 ABCA6 DNAH5	1.93e-04	144	154	7	SM00382
Domain	AAA+_ATPase	ABCA4 DNAH7 ABCC6 DNAH12 MDN1 ABCA6 DNAH5	1.93e-04	144	154	7	IPR003593
Domain	DHC_fam	DNAH7 DNAH12 DNAH5	2.33e-04	15	154	3	IPR026983
Domain	Dynein_heavy	DNAH7 DNAH12 DNAH5	2.33e-04	15	154	3	PF03028
Domain	Dynein_heavy_dom	DNAH7 DNAH12 DNAH5	2.33e-04	15	154	3	IPR004273
Domain	-	DMXL2 GEMIN5 WDR25 BIRC6 TBL3 MST1R WDR38 STRN EML5 WDR44	4.52e-04	333	154	10	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	DMXL2 GEMIN5 WDR25 BIRC6 TBL3 MST1R WDR38 STRN EML5 WDR44	4.73e-04	335	154	10	IPR015943
Domain	ARM-type_fold	ATR CUL7 DOCK5 PPP2R1A MROH8 XPO5 MTOR TARBP1 STAG2 HTT	5.19e-04	339	154	10	IPR016024
Domain	Glyco_hydro_38_C	MAN2C1 MAN2B1	6.65e-04	5	154	2	IPR011682
Domain	Alpha-mann_mid	MAN2C1 MAN2B1	6.65e-04	5	154	2	PF09261
Domain	Glyco_hydro_57/38_cen	MAN2C1 MAN2B1	6.65e-04	5	154	2	IPR028995
Domain	Glyco_hydro_38	MAN2C1 MAN2B1	6.65e-04	5	154	2	PF01074
Domain	Nlgn	NLGN4Y NLGN4X	6.65e-04	5	154	2	IPR000460
Domain	-	MAN2C1 MAN2B1	6.65e-04	5	154	2	1.20.1270.50
Domain	-	MAN2C1 MAN2B1	6.65e-04	5	154	2	3.20.110.10
Domain	Alpha-mann_mid	MAN2C1 MAN2B1	6.65e-04	5	154	2	SM00872
Domain	Glyco_hydro_38_N	MAN2C1 MAN2B1	6.65e-04	5	154	2	IPR000602
Domain	Glyco_hydro_38/57_N	MAN2C1 MAN2B1	6.65e-04	5	154	2	IPR027291
Domain	FATC	ATR MTOR	6.65e-04	5	154	2	PF02260
Domain	Glyco_hydro_38_cen	MAN2C1 MAN2B1	6.65e-04	5	154	2	IPR015341
Domain	Glyco_hydro_38C	MAN2C1 MAN2B1	6.65e-04	5	154	2	PF07748
Domain	G-protein_beta_WD-40_rep	GEMIN5 TBL3 WDR38 STRN WDR44	6.89e-04	85	154	5	IPR020472
Domain	EFhand_Ca_insen	SPTAN1 ACTN2	9.91e-04	6	154	2	PF08726
Domain	EF-hand_Ca_insen	SPTAN1 ACTN2	9.91e-04	6	154	2	IPR014837
Domain	FAT	ATR MTOR	9.91e-04	6	154	2	PS51189
Domain	FATC	ATR MTOR	9.91e-04	6	154	2	PS51190
Domain	FAT	ATR MTOR	9.91e-04	6	154	2	PF02259
Domain	EF-hand_dom_typ1	DRP2 DMD	9.91e-04	6	154	2	IPR015153
Domain	EF-hand_dom_typ2	DRP2 DMD	9.91e-04	6	154	2	IPR015154
Domain	PIK-rel_kinase_FAT	ATR MTOR	9.91e-04	6	154	2	IPR003151
Domain	FATC_dom	ATR MTOR	9.91e-04	6	154	2	IPR003152
Domain	EF-hand_2	DRP2 DMD	9.91e-04	6	154	2	PF09068
Domain	EF-hand_3	DRP2 DMD	9.91e-04	6	154	2	PF09069
Domain	PIK_FAT	ATR MTOR	9.91e-04	6	154	2	IPR014009
Domain	FATC	ATR MTOR	9.91e-04	6	154	2	SM01343
Domain	-	ABCA4 EP400 DDX60 CHD3 DNAH7 ABCC6 SBNO2 DNAH12 MDN1 ABCA6 SBNO1 N4BP2 RHOBTB2 DNAH5 TDRD12	1.30e-03	746	154	15	3.40.50.300
Domain	HEAT	ATR PPP2R1A MTOR HTT	1.33e-03	58	154	4	IPR000357
Domain	Glyco_hydro/deAcase_b/a-brl	MAN2C1 MAN2B1	1.38e-03	7	154	2	IPR011330
Domain	WD40	DMXL2 GEMIN5 WDR25 TBL3 WDR38 STRN EML5 WDR44	1.41e-03	259	154	8	PF00400
Domain	WD40	DMXL2 GEMIN5 WDR25 TBL3 WDR38 STRN EML5 WDR44	1.74e-03	268	154	8	SM00320
Domain	ARM-like	ATR CUL7 PPP2R1A XPO5 MTOR TARBP1 STAG2 HTT	1.83e-03	270	154	8	IPR011989
Domain	WD40_repeat	DMXL2 GEMIN5 WDR25 TBL3 WDR38 STRN EML5 WDR44	1.91e-03	272	154	8	IPR001680
Domain	CH	FLNB SYNE1 ACTN2 DMD	2.04e-03	65	154	4	SM00033
Domain	WD_REPEATS_1	DMXL2 GEMIN5 WDR25 TBL3 WDR38 STRN EML5 WDR44	2.19e-03	278	154	8	PS00678
Domain	WD_REPEATS_2	DMXL2 GEMIN5 WDR25 TBL3 WDR38 STRN EML5 WDR44	2.24e-03	279	154	8	PS50082
Domain	WD_REPEATS_REGION	DMXL2 GEMIN5 WDR25 TBL3 WDR38 STRN EML5 WDR44	2.24e-03	279	154	8	PS50294
Domain	CH	FLNB SYNE1 ACTN2 DMD	2.67e-03	70	154	4	PF00307
Domain	HEAT_REPEAT	ATR PPP2R1A MTOR HTT	2.67e-03	70	154	4	PS50077
Domain	-	FLNB SYNE1 ACTN2 DMD	2.81e-03	71	154	4	1.10.418.10
Domain	CH	FLNB SYNE1 ACTN2 DMD	3.11e-03	73	154	4	PS50021
Domain	EF_hand_dom	RASGRP4 SPTAN1 ITSN1 ACTN2 DNAH7 RYR2 TBC1D9	3.17e-03	232	154	7	IPR002048
Domain	WD40_repeat_dom	DMXL2 GEMIN5 WDR25 TBL3 WDR38 STRN EML5 WDR44	3.28e-03	297	154	8	IPR017986
Domain	CH-domain	FLNB SYNE1 ACTN2 DMD	3.43e-03	75	154	4	IPR001715
Domain	GDS_CDC24_CS	ITSN1 ARHGEF11 TIAM2	4.04e-03	39	154	3	IPR001331
Domain	ABC_A	ABCA4 ABCA6	4.22e-03	12	154	2	IPR026082
Domain	P-loop_NTPase	ABCA4 EP400 DDX60 CHD3 DNAH7 ABCC6 SBNO2 DNAH12 MDN1 ABCA6 SBNO1 N4BP2 RHOBTB2 DNAH5 TDRD12	4.42e-03	848	154	15	IPR027417
Domain	Carboxylesterase_B_CS	NLGN4Y NLGN4X	4.96e-03	13	154	2	IPR019819
Domain	Olfact_rcpt	OR1B1 OR52L1 OR10H4 OR1N2 OR52I2 OR51I1 OR7D2 OR1E2 OR56A3	5.38e-03	393	154	9	IPR000725
Domain	Dynein_HC_stalk	DNAH7 DNAH5	5.76e-03	14	154	2	IPR024743
Domain	CARBOXYLESTERASE_B_2	NLGN4Y NLGN4X	5.76e-03	14	154	2	PS00941
Domain	COesterase	NLGN4Y NLGN4X	5.76e-03	14	154	2	PF00135
Domain	TUDOR	TDRD15 TDRD12	5.76e-03	14	154	2	PF00567
Domain	MT	DNAH7 DNAH5	5.76e-03	14	154	2	PF12777
Domain	CarbesteraseB	NLGN4Y NLGN4X	5.76e-03	14	154	2	IPR002018
Domain	-	DRP2 SPTAN1 ITSN1 ACTN2 RYR2 TBC1D9 DMD	5.99e-03	261	154	7	1.10.238.10
Domain	PI3/4_kinase_CS	ATR MTOR	6.61e-03	15	154	2	IPR018936
Domain	ABC_tran	ABCA4 ABCC6 ABCA6	7.25e-03	48	154	3	PF00005
Domain	HEAT	ATR PPP2R1A HTT	7.25e-03	48	154	3	PF02985
Domain	ABC_TRANSPORTER_2	ABCA4 ABCC6 ABCA6	7.25e-03	48	154	3	PS50893
Domain	-	ATR MTOR	7.51e-03	16	154	2	1.10.1070.11
Domain	Nicotinic_acetylcholine_rcpt	CHRNA3 CHRNB2	7.51e-03	16	154	2	IPR002394
Domain	PI3Kc	ATR MTOR	7.51e-03	16	154	2	SM00146
Domain	ABC_TRANSPORTER_1	ABCA4 ABCC6 ABCA6	7.68e-03	49	154	3	PS00211
Domain	ABC_transporter-like	ABCA4 ABCC6 ABCA6	8.12e-03	50	154	3	IPR003439
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	DMXL2 NLGN4Y ANXA2 ANXA2P2 SYNE1 SPTAN1 PPP2R1A STRN NLGN4X MTOR KCTD16	8.99e-08	281	161	11	28706196
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	UTP6 ABCA4 DRP2 ITGA3 RFX1 DNAH7 TBL3 ABCC6 RYR2 TPK1 DNAH12 MDN1 KDM6A TARBP1 STAG2	3.20e-07	638	161	15	31182584
Pubmed	Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are affected by autism-related mutations.	NLGN4Y NLGN4X SNTG2	3.88e-07	4	161	3	17292328
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MAN2B1 EP400 TMC6 GEMIN5 PIGG ITGA3 ARHGEF11 BIRC6 TBC1D9 TIAM2 SBNO2 MST1R MDN1 SLC16A5 MTOR CSPG4 PIGW RGL2 HTT	9.73e-07	1105	161	19	35748872
Pubmed	Dystrophin stabilizes alpha 3- but not alpha 7-containing nicotinic acetylcholine receptor subtypes at the postsynaptic apparatus in the mouse superior cervical ganglion.	CHRNA3 CHRNB2 DMD	1.93e-06	6	161	3	12079404
Pubmed	Annexin A2 Regulates Autophagy in Pseudomonas aeruginosa Infection through the Akt1-mTOR-ULK1/2 Signaling Pathway.	ANXA2 ANXA2P2 MTOR	1.93e-06	6	161	3	26371245
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	UTP6 FLNB ATP6V0A1 ATR ANXA2 SYNE1 SPTAN1 GART GEMIN5 TBL3 PPP2R1A CS MROH8 MDN1 SBNO1 XPO5 MTOR KCTD16 MTR DNAH5 STAG2	2.92e-06	1425	161	21	30948266
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	LARGE2 TICRR FLNB ITSN1 CYP27B1 GEMIN5 CHD3 NCSTN TMBIM6 TIAM2 SBNO2 BRD8 EML5 FEZ2 LRP2 PIGW FAM216A STAG2	3.11e-06	1084	161	18	11544199
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	FLNB EP400 SPTAN1 GEMIN5 CHD3 FBXO38 PPP2R1A MDN1 XPO5 STAG2	3.73e-06	332	161	10	32786267
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	FLNB ATR ANXA2 DDX60 GEMIN5 DOCK5 XPO5 MTOR	4.95e-06	202	161	8	33005030
Pubmed	Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome protein CCDC8.	CUL7 ARHGEF11 FAM83B HTT	8.31e-06	28	161	4	25752541
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	TICRR FLNB CYP26B1 ITSN1 OR52L1 BIRC6 PCDH17 DOCK5 MROH8 MDN1 LRP2 PIGW KAZN DOP1B	9.22e-06	736	161	14	29676528
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	UTP6 FLNB SPTAN1 GART GEMIN5 CUL7 BIRC6 TBL3 PPP2R1A MDN1 XPO5 MTOR STAG2	1.21e-05	653	161	13	22586326
Pubmed	gamma-Syntrophin scaffolding is spatially and functionally distinct from that of the alpha/beta syntrophins.	DRP2 SNTG2 DMD	1.56e-05	11	161	3	16857187
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATR EP400 SPTAN1 ITSN1 GEMIN5 CHD3 RFX1 TBC1D9 FBXO38 BRD8 MDN1 KDM6A STAG2 WDR44	1.61e-05	774	161	14	15302935
Pubmed	Identification of Annexin A2 as a key mTOR target to induce roller coaster pattern of autophagy fluctuation in stress.	ANXA2 MTOR	2.13e-05	2	161	2	32841734
Pubmed	Crosstalk between RyR2 oxidation and phosphorylation contributes to cardiac dysfunction in mice with Duchenne muscular dystrophy.	RYR2 DMD	2.13e-05	2	161	2	26555638
Pubmed	Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.	ANXA2 ANXA2P2	2.13e-05	2	161	2	19536308
Pubmed	Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate.	ANXA2 ANXA2P2	2.13e-05	2	161	2	23148505
Pubmed	Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain.	JAK1 IL21R	2.13e-05	2	161	2	11016959
Pubmed	ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.	ANXA2 ANXA2P2	2.13e-05	2	161	2	38290972
Pubmed	The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats.	ANXA2 ANXA2P2	2.13e-05	2	161	2	3013423
Pubmed	Activation of Annexin A2 signaling at the blood-brain barrier in a mouse model of multiple sclerosis.	ANXA2 ANXA2P2	2.13e-05	2	161	2	35064931
Pubmed	Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans.	ANXA2 ANXA2P2	2.13e-05	2	161	2	28130864
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	2.13e-05	2	161	2	23183221
Pubmed	Localization of annexin II in the paranodal regions and Schmidt-Lanterman incisures in the peripheral nervous system.	ANXA2 ANXA2P2	2.13e-05	2	161	2	17549680
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4Y NLGN4X	2.13e-05	2	161	2	24855039
Pubmed	Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice.	ANXA2 ANXA2P2	2.13e-05	2	161	2	39384746
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4Y NLGN4X	2.13e-05	2	161	2	37001827
Pubmed	Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells.	ANXA2 ANXA2P2	2.13e-05	2	161	2	20826156
Pubmed	Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue.	ANXA2 ANXA2P2	2.13e-05	2	161	2	27468426
Pubmed	Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.	ANXA2 ANXA2P2	2.13e-05	2	161	2	19841537
Pubmed	PKC theta ablation improves healing in a mouse model of muscular dystrophy.	PRKCQ DMD	2.13e-05	2	161	2	22348094
Pubmed	Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.	PRKCQ DMD	2.13e-05	2	161	2	28089792
Pubmed	The structures of the human neuronal nicotinic acetylcholine receptor beta2- and alpha3-subunit genes (CHRNB2 and CHRNA3).	CHRNA3 CHRNB2	2.13e-05	2	161	2	9921897
Pubmed	Annexin A2 Modulates ROS and Impacts Inflammatory Response via IL-17 Signaling in Polymicrobial Sepsis Mice.	ANXA2 ANXA2P2	2.13e-05	2	161	2	27389701
Pubmed	Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation.	ANXA2 ANXA2P2	2.13e-05	2	161	2	17360942
Pubmed	Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina.	ANXA2 ANXA2P2	2.13e-05	2	161	2	19587120
Pubmed	Annexin A2 at the interface between F-actin and membranes enriched in phosphatidylinositol 4,5,-bisphosphate.	ANXA2 ANXA2P2	2.13e-05	2	161	2	19022301
Pubmed	Multi-Omics Profiling Identifies Microglial Annexin A2 as a Key Mediator of NF-κB Pro-inflammatory Signaling in Ischemic Reperfusion Injury.	ANXA2 ANXA2P2	2.13e-05	2	161	2	38253182
Pubmed	The decrease of expression of ryanodine receptor sub-type 2 is reversed by gentamycin sulphate in vascular myocytes from mdx mice.	RYR2 DMD	2.13e-05	2	161	2	19298530
Pubmed	Morphogenesis in Aspergillus nidulans requires Dopey (DopA), a member of a novel family of leucine zipper-like proteins conserved from yeast to humans.	DOP1A DOP1B	2.13e-05	2	161	2	10931277
Pubmed	Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis.	ANXA2 ANXA2P2	2.13e-05	2	161	2	22185818
Pubmed	Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease.	RYR2 HTT	2.13e-05	2	161	2	32897880
Pubmed	A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events.	ANXA2 ANXA2P2	2.13e-05	2	161	2	21486955
Pubmed	Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma.	SBNO2 SBNO1	2.13e-05	2	161	2	36695974
Pubmed	Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2.	ANXA2 ANXA2P2	2.13e-05	2	161	2	21737841
Pubmed	Lack of PKCθ Promotes Regenerative Ability of Muscle Stem Cells in Chronic Muscle Injury.	PRKCQ DMD	2.13e-05	2	161	2	32023816
Pubmed	Regulation of the low-dose radiation paracrine-specific anchorage-independent growth response by annexin A2.	ANXA2 ANXA2P2	2.13e-05	2	161	2	19580511
Pubmed	Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.	CPB2 F5	2.13e-05	2	161	2	12165290
Pubmed	Impulsivity and aggression in alcohol withdrawal syndrome is modulated by the interaction of ZNF804A and mTOR polymorphism.	ZNF804A MTOR	2.13e-05	2	161	2	38216065
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4Y NLGN4X	2.13e-05	2	161	2	18434543
Pubmed	Receptor-mediated tobacco toxicity: regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells.	CHRNA3 CHRNB2	2.13e-05	2	161	2	15681842
Pubmed	Alternative splicing-derived intersectin1-L and intersectin1-S exert opposite function in glioma progression.	ANXA2 ITSN1	2.13e-05	2	161	2	31160551
Pubmed	Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeable.	ACTN2 DMD	2.13e-05	2	161	2	12140183
Pubmed	Selenomethionine promotes ANXA2 phosphorylation for proliferation and protein synthesis of myoblasts and skeletal muscle growth.	ANXA2 ANXA2P2	2.13e-05	2	161	2	36739096
Pubmed	Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.	ANXA2 ANXA2P2	2.13e-05	2	161	2	22517898
Pubmed	Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway.	ANXA2 ANXA2P2	2.13e-05	2	161	2	30462534
Pubmed	Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins.	MTOR DMD	2.13e-05	2	161	2	23115080
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4Y NLGN4X	2.13e-05	2	161	2	37080762
Pubmed	Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis.	ANXA2 ANXA2P2	2.13e-05	2	161	2	38092984
Pubmed	Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.	ANXA2 ANXA2P2	2.13e-05	2	161	2	21572519
Pubmed	ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum.	ABCA4 ABCC6	2.13e-05	2	161	2	12673275
Pubmed	Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice.	ANXA2 ANXA2P2	2.13e-05	2	161	2	21788340
Pubmed	The Membrane Phospholipid Binding Protein Annexin A2 Promotes Phagocytosis and Nonlytic Exocytosis of Cryptococcus neoformans and Impacts Survival in Fungal Infection.	ANXA2 ANXA2P2	2.13e-05	2	161	2	27371724
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4Y NLGN4X	2.13e-05	2	161	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4Y NLGN4X	2.13e-05	2	161	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4Y NLGN4X	2.13e-05	2	161	2	24104404
Pubmed	Annexin A2 Deficiency Exacerbates Neuroinflammation and Long-Term Neurological Deficits after Traumatic Brain Injury in Mice.	ANXA2 ANXA2P2	2.13e-05	2	161	2	31817350
Pubmed	ANNEXIN A2 FACILITATES NEOVASCULARIZATION TO PROTECT AGAINST MYOCARDIAL INFARCTION INJURY VIA INTERACTING WITH MACROPHAGE YAP AND ENDOTHELIAL INTEGRIN Β3.	ANXA2 ANXA2P2	2.13e-05	2	161	2	37832154
Pubmed	Cell-surface translocation of annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice.	ANXA2 ANXA2P2	2.13e-05	2	161	2	30902828
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4Y NLGN4X	2.13e-05	2	161	2	32243781
Pubmed	Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis.	ANXA2 ANXA2P2	2.13e-05	2	161	2	24742684
Pubmed	Sympathetic α₃β₂-nAChRs mediate cerebral neurogenic nitrergic vasodilation in the swine.	CHRNA3 CHRNB2	2.13e-05	2	161	2	21536845
Pubmed	Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections.	ANXA2 ANXA2P2	2.13e-05	2	161	2	32687500
Pubmed	Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris.	ANXA2 ANXA2P2	2.13e-05	2	161	2	22453828
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4Y NLGN4X	2.13e-05	2	161	2	22989184
Pubmed	Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.	RYR2 DMD	2.13e-05	2	161	2	30181262
Pubmed	Agents that bind annexin A2 suppress ocular neovascularization.	ANXA2 ANXA2P2	2.13e-05	2	161	2	20607799
Pubmed	Expression of the Abca-subfamily of genes in Abcc6-/- mice--upregulation of Abca4.	ABCA4 ABCC6	2.13e-05	2	161	2	21435020
Pubmed	A new role for host annexin A2 in establishing bacterial adhesion to vascular endothelial cells: lines of evidence from atomic force microscopy and an in vivo study.	ANXA2 ANXA2P2	2.13e-05	2	161	2	31253864
Pubmed	Prefrontal nicotinic receptors control novel social interaction between mice.	CHRNB2 DMD	2.13e-05	2	161	2	21402717
Pubmed	Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.	ANXA2 ANXA2P2	2.13e-05	2	161	2	19628708
Pubmed	Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA.	ANXA2 ANXA2P2	2.13e-05	2	161	2	15654879
Pubmed	Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis.	ANXA2 ANXA2P2	2.13e-05	2	161	2	20847146
Pubmed	Targeting early PKCθ-dependent T-cell infiltration of dystrophic muscle reduces disease severity in a mouse model of muscular dystrophy.	PRKCQ DMD	2.13e-05	2	161	2	29214629
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	UTP6 FLNB EP400 ANXA2 SYNE1 GART HAUS5 CHD3 CUL7 F5 TBL3 FAM83B PPP2R1A CS MDN1 STAG2	2.38e-05	1024	161	16	24711643
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FLNB SPTAN1 ITSN1 GART CHD3 JAK1 FNDC11 ADGRL2 DNAH5	2.65e-05	332	161	9	37433992
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR1B1 OR52L1 OR4E1 OR10H4 OR1N2 OR52I2 OR51I1 OR1E2 OR56A3	3.19e-05	340	161	9	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR1B1 OR52L1 OR4E1 OR10H4 OR1N2 OR52I2 OR51I1 OR1E2 OR56A3	3.19e-05	340	161	9	11802173
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR1B1 OR52L1 OR4E1 OR10H4 OR1N2 OR52I2 OR51I1 OR1E2 OR56A3	3.41e-05	343	161	9	32295537
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH7 DNAH12 DNAH5	3.41e-05	14	161	3	9373155
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR1B1 OR52L1 OR4E1 OR10H4 OR1N2 OR52I2 OR51I1 OR1E2 OR56A3	3.65e-05	346	161	9	14611657
Pubmed	Deletion of Sarcolemmal Membrane-Associated Protein Isoform 3 (SLMAP3) in Cardiac Progenitors Delays Embryonic Growth of Myocardium without Affecting Hippo Pathway.	PPP2R1A STRN MTOR	4.25e-05	15	161	3	38474134
Pubmed	The human olfactory receptor gene family.	OR1B1 OR52L1 OR4E1 OR10H4 OR1N2 OR52I2 OR51I1 OR52L2P OR7D2 OR1E2 OR56A3	4.77e-05	541	161	11	14983052
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	EP400 ANXA2 SPTAN1 HAUS5 GEMIN5 RFX1 PPP2R1A BRD8 KDM6A HTT WDR44	5.44e-05	549	161	11	38280479
Pubmed	A genetic analysis of neural progenitor differentiation.	ANXA2 ANXA2P2 PBK	6.31e-05	17	161	3	11239426
Pubmed	STARD3NL inhibits the osteogenic differentiation by inactivating the Wnt/β-catenin pathway via binding to Annexin A2 in osteoporosis.	ANXA2 ANXA2P2	6.37e-05	3	161	2	35098646
Pubmed	Huntingtin associates with the actin cytoskeleton and α-actinin isoforms to influence stimulus dependent morphology changes.	ACTN2 HTT	6.37e-05	3	161	2	30768638
Pubmed	The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.	ANXA2 ANXA2P2	6.37e-05	3	161	2	35413401
Interaction	NPTN interactions	DMXL2 ATR GEMIN5 FCSK MDN1 XPO5 MTOR TARBP1 STAG2 HTT DOP1A DOP1B	1.03e-06	278	148	12	int:NPTN
Interaction	GPR182 interactions	ATR TM9SF1 TMC6 PIGG DIPK2A DOCK5 JAK1 FCSK MDN1 XPO5 MTOR EPHX4 TARBP1 HTT DOP1B	1.36e-06	455	148	15	int:GPR182
GeneFamily	Dyneins, axonemal	DNAH7 DNAH12 DNAH5	1.77e-04	17	119	3	536
GeneFamily	WD repeat domain containing	DMXL2 GEMIN5 WDR25 TBL3 WDR38 STRN EML5 WDR44	3.43e-04	262	119	8	362
GeneFamily	Mannosidases alpha class 2	MAN2C1 MAN2B1	4.24e-04	5	119	2	1194
GeneFamily	WD repeat domain containing\|UTPB complex	UTP6 TBL3	6.33e-04	6	119	2	1225
GeneFamily	Olfactory receptors, family 1	OR1B1 OR1N2 OR1E2	2.30e-03	40	119	3	147
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_DC_DN	MAN2B1 ANXA2 ANXA2P2 TM9SF1 NCSTN ARHGEF11 ZNF804A FEZ2 HTT	3.50e-06	200	157	9	M4492
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1A SLC17A4 ITGA3 DNAH7 LRFN5 KCTD16 LRP2 KAZN	1.76e-07	168	160	8	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CYP26B1 TRPC5 ACTN2 PCDH17 DIPK2A KCTD16 DMD ADGRL2	3.83e-07	186	160	8	77b09af860183606a1775eba921e2071e4a7dd4e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A NLGN4Y ITGA3 FAM83B SLC16A5 KCTD16 PRKCQ KAZN	4.50e-07	190	160	8	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A NLGN4Y ITGA3 FAM83B SLC16A5 KCTD16 PRKCQ KAZN	4.50e-07	190	160	8	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A SYNE1 ITGA3 DNAH7 SLC16A5 PRKCQ KAZN DNAH5	4.50e-07	190	160	8	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A NLGN4Y ITGA3 DNAH7 SLC16A5 PRKCQ KAZN DNAH5	4.68e-07	191	160	8	5a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A NLGN4Y ITGA3 DNAH7 SLC16A5 PRKCQ KAZN DNAH5	4.68e-07	191	160	8	55ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A SYNE1 ITGA3 DNAH7 STRN SLC16A5 KAZN DNAH5	5.07e-07	193	160	8	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A SYNE1 ITGA3 DNAH7 STRN SLC16A5 KAZN DNAH5	5.07e-07	193	160	8	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A SYNE1 ITGA3 DNAH7 STRN SLC16A5 KAZN DNAH5	5.27e-07	194	160	8	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	PDE1A NLGN4Y ITGA3 FAM83B SLC16A5 PRKCQ KAZN DNAH5	5.70e-07	196	160	8	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNE1 RYR2 FRMD4A LRFN5 KCTD16 KAZN ADGRL2 TARBP1	6.15e-07	198	160	8	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	PDE1A SYNE1 RYR2 FRMD4A CSPG4 SNTG2 SLC38A11 DMD	6.63e-07	200	160	8	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	ABCA4 F5 DNAH7 WDR38 DNAH12 SLC38A11 DNAH5 IQCG	6.63e-07	200	160	8	177f9ad8dd8635394c575a2b30140184df0bd51e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 ITGA3 F5 FRMD4A PIANP LRFN5 EPHX4	1.57e-06	156	160	7	dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 ITGA3 F5 FRMD4A PIANP LRFN5 EPHX4	1.57e-06	156	160	7	abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE1A TRPC5 ZNF804A PCDH17 KCTD16 DMD ADGRL2	4.37e-06	182	160	7	205d9ad1ea4b7adee8054496cdde46c9c401a19a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CYP26B1 TRPC5 ACTN2 PCDH17 KCTD16 DMD ADGRL2	4.70e-06	184	160	7	ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4Y ANXA2 ITGA3 FAM83B MST1R SLC16A5 DNAH5	5.23e-06	187	160	7	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4Y ANXA2 ITGA3 FAM83B MST1R SLC16A5 DNAH5	5.23e-06	187	160	7	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4Y ANXA2 ITGA3 FAM83B MST1R SLC16A5 DNAH5	5.23e-06	187	160	7	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A SYNE1 ITGA3 F5 FRMD4A LRFN5 KAZN	5.41e-06	188	160	7	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A SYNE1 ITGA3 F5 FRMD4A LRFN5 KAZN	5.41e-06	188	160	7	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A NLGN4Y ITGA3 FAM83B KCTD16 PRKCQ KAZN	6.00e-06	191	160	7	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A ITGA3 STRN SLC16A5 PRKCQ KAZN DNAH5	6.43e-06	193	160	7	263d185af6ed80e639f864e4966268e0862c61dc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A ITGA3 STRN SLC16A5 PRKCQ KAZN DNAH5	6.43e-06	193	160	7	80e058c224749b5fe0ba3e944b48317c2371cb63
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A ITGA3 STRN SLC16A5 PRKCQ KAZN DNAH5	6.43e-06	193	160	7	b991fbbb4618401624f0b3045f0e81a606d3a763
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4Y ITGA3 STRN SLC16A5 PRKCQ KAZN DNAH5	6.87e-06	195	160	7	938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4Y ITGA3 STRN SLC16A5 PRKCQ KAZN DNAH5	6.87e-06	195	160	7	d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNE1 RYR2 FRMD4A LRFN5 KCTD16 ADGRL2 TARBP1	7.11e-06	196	160	7	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNE1 RYR2 FRMD4A LRFN5 KCTD16 ADGRL2 TARBP1	7.59e-06	198	160	7	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDE1A SYNE1 RYR2 FRMD4A CSPG4 SLC38A11 DMD	8.11e-06	200	160	7	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDE1A SYNE1 RYR2 FRMD4A CSPG4 SLC38A11 DMD	8.11e-06	200	160	7	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TICRR PBK RYR2 FAM83B ANKRD61 SNTG2	8.33e-06	132	160	6	02491930097b75aaeedab9e8200711b0dc610944
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DDX60 TM6SF2 PCDH17 MTOR ALG14 ADGRL2	2.15e-05	156	160	6	6c8f442ed94ae31e6832b68137e98ae78091ac6c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ACTN2 F5 DIPK2A FRMD4A LRFN5 SNTG2	2.40e-05	159	160	6	9f6607e395bcca9cb1c83199bdbbaaa62a93938d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ACTN2 F5 DIPK2A FRMD4A LRFN5 SNTG2	2.40e-05	159	160	6	c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Htr2c_(Lateral_habenula)\|Thalamus / BrainAtlas - Mouse McCarroll V32	MAN2C1 ABHD10 DYRK4 TM6SF2 ANKRD61	2.92e-05	99	160	5	3dd31ed90bd1655cad954045afaef50de889008b
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPEPLD PGLYRP2 TPK1 XPO5 IL21R SLC38A11	2.95e-05	165	160	6	475905d608fac628960188ae4a18010b8097417e
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR MAN2B1 SYNE1 NTS TM6SF2 F5	3.38e-05	169	160	6	b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR MAN2B1 SYNE1 NTS TM6SF2 F5	3.38e-05	169	160	6	83d1bcf33872b01ea9614f608a3e4ab30df25c7e
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 DMXL2 ANXA2 SYNE1 F5 DOCK5	3.61e-05	171	160	6	ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 DMXL2 ANXA2 SYNE1 F5 DOCK5	3.61e-05	171	160	6	97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	PDE1A SYNE1 FRMD4A LRFN5 LRP2 KAZN	3.73e-05	172	160	6	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	COVID-19_Mild-PLT_2\|COVID-19_Mild / Disease Group and Platelet Clusters	HAUS5 PGLYRP2 DYRK4 F5 TBL3 TARBP1	3.85e-05	173	160	6	d11705e56b6b21eec963ea224717f27680c781ed
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN2 CHRNB2 EML5 SLC16A5 IL21R PRKCQ	4.51e-05	178	160	6	a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1A SLC17A4 DNAH7 LRFN5 LRP2 KAZN	4.51e-05	178	160	6	544379f5a6145429762258d426b876bb36c112f5
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD4+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN2 CHRNB2 EML5 SLC16A5 IL21R PRKCQ	4.51e-05	178	160	6	5ecbea15efd304057aef826ec2f385997bfaf0c9
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC5 ACTN2 ZNF804A PCDH17 SNTG2 DMD	4.66e-05	179	160	6	1ac79c82c52fa95bb4e170ab20fec0f648db2134
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 NAPEPLD KCTD16 SNTG2 PRKCQ SLC38A11	4.95e-05	181	160	6	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 NAPEPLD KCTD16 SNTG2 PRKCQ SLC38A11	5.11e-05	182	160	6	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA2 ITGA3 F5 ZNF804A DOCK5 FLRT3	5.26e-05	183	160	6	612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCell	droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LARGE2 ATP6V0A1 TBC1D9 SLC7A4 DMD ADGRL2	5.26e-05	183	160	6	ffb1bbbccb34d1a7e99872611f497450039d5019
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA2 ITGA3 F5 ZNF804A DOCK5 FLRT3	5.26e-05	183	160	6	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 DRP2 RYR2 LRP2 DMD DNAH5	5.43e-05	184	160	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 DRP2 RYR2 LRP2 DMD DNAH5	5.43e-05	184	160	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 DRP2 RYR2 LRP2 DMD DNAH5	5.43e-05	184	160	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A SYNE1 F5 FRMD4A LRFN5 KAZN	5.59e-05	185	160	6	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A SYNE1 F5 FRMD4A LRFN5 KAZN	5.59e-05	185	160	6	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE1A ITGA3 ABCC6 RHOBTB2 DMD DNAH5	5.76e-05	186	160	6	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1A SYNE1 RYR2 FRMD4A SLC38A11 DMD	5.76e-05	186	160	6	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NLGN4Y PIANP NLGN4X ABCA6 LRFN5 ADGRL2	5.76e-05	186	160	6	f07e0c0d9c80ac9d8d679950e7d0c812becb85a3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 SYNE1 DNAH7 PRKCQ KAZN SLC38A11	5.76e-05	186	160	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1A RYR2 FRMD4A CSPG4 SLC38A11 DMD	5.76e-05	186	160	6	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	COVID-19-kidney-Mito-rich_Distal\|kidney / Disease (COVID-19 only), tissue and cell type	PDE1A NLGN4Y FAM83B PRKCQ KAZN DNAH5	5.93e-05	187	160	6	2ce8038d9d1302e850c1bb536e755598f77ba4b9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4Y ITGA3 FAM83B SLC16A5 ABCA6 ADGRL2	5.93e-05	187	160	6	77886f99c229610abd28c4c370d2c7d1536c9782
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	FLNB CPB2 ABCC6 MTR SLC38A11 DMD	5.93e-05	187	160	6	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1A RYR2 FRMD4A CSPG4 SLC38A11 DMD	6.29e-05	189	160	6	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	6.48e-05	190	160	6	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	6.48e-05	190	160	6	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	wk_20-22-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PDE1A ABCA4 NPY5R ANXA2 NTS SNTG2	6.48e-05	190	160	6	103e78c2233c3ee0c215a9dafe70705477e9ee5e
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PDE1A DNAH7 KCTD16 LRP2 DMD DNAH5	6.67e-05	191	160	6	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	COVID-19-kidney-TAL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1A NLGN4Y ITGA3 FAM83B PRKCQ KAZN	6.67e-05	191	160	6	fe55475ce0666ab5122447a813dc2369e24947b8
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH12 UBE2G1 CD79B UGT2B11 EPHX4	6.76e-05	118	160	5	bc65345ee8e59fbda60f345696192376cdbf54b8
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	6.87e-05	192	160	6	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LARGE2 PDE1A DNAH7 LRP2 SLC38A11 DMD	6.87e-05	192	160	6	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	7.07e-05	193	160	6	0b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA2 ITGA3 TBC1D9 FAM83B KAZN DOP1B	7.27e-05	194	160	6	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA2 ITGA3 TBC1D9 FAM83B KAZN DOP1B	7.27e-05	194	160	6	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	7.27e-05	194	160	6	b4ce60c06568123008b1081d644733cb91c28f51
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	7.27e-05	194	160	6	7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PDE1A DNAH7 KCTD16 LRP2 DMD DNAH5	7.27e-05	194	160	6	6b286992d4bb56013c0ea5a7601d3476d806175a
ToppCell	COVID-19_Mild-Non-classical_Monocyte\|COVID-19_Mild / Disease condition and Cell class	TMC6 PGLYRP2 TIAM2 CKS1B IL21R CD79B	7.48e-05	195	160	6	dd00facd20a661ef23fa7fd9a02ee377b8f2d1b9
ToppCell	COVID-19_Mild-Non-classical_Monocyte-\|COVID-19_Mild / Disease condition and Cell class	TMC6 PGLYRP2 TIAM2 CKS1B IL21R CD79B	7.48e-05	195	160	6	0295d9897830987eec74f51178e14fb0a83723dc
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA2 SYNE1 F5 LRFN5 FLRT3 IQCG	7.69e-05	196	160	6	34e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA2 SYNE1 F5 LRFN5 FLRT3 IQCG	7.69e-05	196	160	6	8f82e01ca50aa4cd6149547505b4474a02fad618
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41\|World / Primary Cells by Cluster	PDE1A ITSN1 NTS FRMD4A KCTD16 FLRT3	7.69e-05	196	160	6	dee0984cd63a1a2fdebb4421af48ab566a5b684e
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	7.91e-05	197	160	6	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	7.91e-05	197	160	6	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	7.91e-05	197	160	6	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	7.91e-05	197	160	6	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	wk_08-11-Epithelial-PNS\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ZNF804A CHRNA3 PCDH17 NLGN4X EML5 FLRT3	7.91e-05	197	160	6	ce3f9feb6935f0e9daf13673b0a0d6e92817e187
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	7.91e-05	197	160	6	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNE1 RYR2 FRMD4A LRFN5 KCTD16 ADGRL2	8.14e-05	198	160	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	8.14e-05	198	160	6	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RYR2 FRMD4A LRFN5 KAZN ADGRL2 TARBP1	8.14e-05	198	160	6	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	proximal-Epithelial-Ciliated\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH7 WDR38 DNAH12 FNDC11 DNAH5 IQCG	8.36e-05	199	160	6	9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76
ToppCell	proximal-3-Epithelial-Ciliated\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH7 WDR38 DNAH12 FNDC11 DNAH5 IQCG	8.36e-05	199	160	6	1188afad6fd5f01f9aeba225f611f38b237dd2c9
ToppCell	proximal-Epithelial-Ciliated-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH7 WDR38 DNAH12 FNDC11 DNAH5 IQCG	8.36e-05	199	160	6	2e8ace105c4e2405baa06d953e52888b54e2d055
ToppCell	(10)_Ciliated\|World / shred by cell type by condition	SYNE1 DNAH7 WDR38 DNAH12 DNAH5 IQCG	8.60e-05	200	160	6	1b6a8025bd2746b626040058c122b1be3ab2fa61
Drug	Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A	SPTAN1 HAUS5 CUL7 ARHGEF11 ZNF804A RYR2 SBNO2 LRP2 CD79B KAZN	1.00e-06	195	156	10	5399_DN
Disease	Neoplasm of uncertain or unknown behavior of bladder	FANCC MTOR KDM6A STAG2	8.16e-07	15	149	4	C0496930
Disease	Benign neoplasm of bladder	FANCC MTOR KDM6A STAG2	8.16e-07	15	149	4	C0154017
Disease	Carcinoma in situ of bladder	FANCC MTOR KDM6A STAG2	8.16e-07	15	149	4	C0154091
Disease	Carcinoma of bladder	FANCC MTOR KDM6A STAG2	1.81e-06	18	149	4	C0699885
Disease	lung small cell carcinoma (is_implicated_in)	CHRNA3 XPO5 MTOR KDM6A	1.16e-05	28	149	4	DOID:5409 (is_implicated_in)
Disease	alpha-Mannosidosis	MAN2C1 MAN2B1	2.53e-05	2	149	2	C0024748
Disease	Schizophrenia	NTS ARHGEF11 ZNF804A CHRNA3 PCDH17 CHRNB2 SBNO2 UGT1A3 SLC6A11 EML5 SBNO1 MTOR HHAT LRP2 MTR	4.34e-05	883	149	15	C0036341
Disease	Intellectual Disability	SYNE1 CHD3 FCSK PPP2R1A MTOR ALG14 RHOBTB2 LRP2 STAG2 HTT	9.67e-05	447	149	10	C3714756
Disease	guanylyl cyclase-activating protein 1 measurement	PGLYRP2 F5	1.51e-04	4	149	2	EFO_0801663
Disease	amino acid measurement	UTP6 SYNE1 WDR25 DNAH7 RYR2 DIPK2A DNAH12 HHAT LRP2 CD79B ADGRL2 HTT	1.78e-04	678	149	12	EFO_0005134
Disease	adenoid cystic carcinoma (is_implicated_in)	ATR KDM6A	2.51e-04	5	149	2	DOID:0080202 (is_implicated_in)
Disease	response to bevacizumab, Proteinuria	JAK1 DNAH5	2.51e-04	5	149	2	EFO_0005943, HP_0000093
Disease	schizophrenia (implicated_via_orthology)	NCSTN ZNF804A SBNO1 MTOR	3.96e-04	68	149	4	DOID:5419 (implicated_via_orthology)
Disease	pulse pressure measurement, anxiety	CHD3 GJA9	5.23e-04	7	149	2	EFO_0005230, EFO_0005763
Disease	internet addiction disorder	FLNB NPY5R ZNF804A	6.16e-04	33	149	3	EFO_0803368
Disease	Chronic pain	PRKCQ KAZN	6.95e-04	8	149	2	HP_0012532
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	DRP2 SNTG2 DMD	7.97e-04	36	149	3	DOID:11723 (implicated_via_orthology)
Disease	Colorectal Carcinoma	ABCA4 SYNE1 F5 ZNF804A ABCC6 NLGN4X ABCA6 OR1E2 LRP2 DMD KDM6A	9.10e-04	702	149	11	C0009402
Disease	Autism Spectrum Disorders	RYR2 DIPK2A NLGN4X SNTG2	9.21e-04	85	149	4	C1510586
Disease	autism spectrum disorder (implicated_via_orthology)	NLGN4Y TRPC5 CHRNB2 PIANP NLGN4X	1.07e-03	152	149	5	DOID:0060041 (implicated_via_orthology)
Disease	free cholesterol in medium LDL measurement	TDRD15 TM6SF2 ABCA6	1.09e-03	40	149	3	EFO_0022268
Disease	Kunitz-type protease inhibitor 2 measurement	RASGRP4 KCNK6	1.11e-03	10	149	2	EFO_0008200
Disease	arrhythmogenic right ventricular cardiomyopathy (is_implicated_in)	ACTN2 RYR2	1.11e-03	10	149	2	DOID:0050431 (is_implicated_in)
Disease	carboxypeptidase B2 measurement	CPB2 SNTG2	1.11e-03	10	149	2	EFO_0008069
Disease	osteonecrosis (is_implicated_in)	ANXA2 F5	1.11e-03	10	149	2	DOID:10159 (is_implicated_in)
Disease	plasma trimethylamine N-oxide measurement	UBE2G1 RHOBTB2	1.11e-03	10	149	2	EFO_0005691
Disease	ovarian carcinoma	ABCA4 ZNF804A BRD8 UBE2G1 N4BP2 GPX6 DMD	1.27e-03	321	149	7	EFO_0001075
Disease	concentration of large LDL particles measurement	TDRD15 TM6SF2 ABCA6	1.44e-03	44	149	3	EFO_0022160
Disease	cholesterol in medium VLDL measurement	TDRD15 TM6SF2 ABCA6	1.44e-03	44	149	3	EFO_0022225
Disease	upper aerodigestive tract neoplasm	C6orf89 BIRC6 PCDH17 STRN GPX6 ADGRL2	1.61e-03	246	149	6	EFO_0004284
Disease	diffuse large B-cell lymphoma (is_implicated_in)	IL21R CD79B	1.62e-03	12	149	2	DOID:0050745 (is_implicated_in)
Disease	3-formylindole measurement	SLC17A4 KYAT1	1.90e-03	13	149	2	EFO_0801025
Disease	salicylurate measurement	B3GALT1 RYR2	1.90e-03	13	149	2	EFO_0010532
Disease	X-19141 measurement	SLC17A4 UGT2B11	1.90e-03	13	149	2	EFO_0800799
Disease	phospholipids in medium LDL measurement	TDRD15 TM6SF2 ABCA6	1.96e-03	49	149	3	EFO_0022183
Disease	free cholesterol in LDL measurement	TDRD15 TM6SF2 ABCA6	2.08e-03	50	149	3	EFO_0022266
Disease	free cholesterol in large LDL measurement	TDRD15 TM6SF2 ABCA6	2.20e-03	51	149	3	EFO_0022176
Disease	renal cell carcinoma (biomarker_via_orthology)	ANXA2 ANXA2P2	2.21e-03	14	149	2	DOID:4450 (biomarker_via_orthology)
Disease	phospholipids in IDL measurement	TDRD15 TM6SF2 ABCA6	2.33e-03	52	149	3	EFO_0022164
Disease	total lipids in LDL measurement	TDRD15 TM6SF2 ABCA6	2.33e-03	52	149	3	EFO_0022308
Disease	phospholipids in large LDL measurement	TDRD15 TM6SF2 ABCA6	2.46e-03	53	149	3	EFO_0022174
Disease	free cholesterol in small LDL measurement	TDRD15 TM6SF2 ABCA6	2.46e-03	53	149	3	EFO_0022271
Disease	Down syndrome (implicated_via_orthology)	DOP1A DOP1B	2.55e-03	15	149	2	DOID:14250 (implicated_via_orthology)
Disease	Antithrombotic agent use measurement	TDRD15 F5 FANCC	2.73e-03	55	149	3	EFO_0009925
Disease	Drug habituation	SYNE1 ZNF804A TIAM2 FRMD4A	2.80e-03	115	149	4	C0013170
Disease	Drug abuse	SYNE1 ZNF804A TIAM2 FRMD4A	2.80e-03	115	149	4	C0013146
Disease	Prescription Drug Abuse	SYNE1 ZNF804A TIAM2 FRMD4A	2.80e-03	115	149	4	C4316881
Disease	Substance-Related Disorders	SYNE1 ZNF804A TIAM2 FRMD4A	2.80e-03	115	149	4	C0236969
Disease	Drug Use Disorders	SYNE1 ZNF804A TIAM2 FRMD4A	2.80e-03	115	149	4	C0013222
Disease	Drug Dependence	SYNE1 ZNF804A TIAM2 FRMD4A	2.80e-03	115	149	4	C1510472
Disease	Substance Dependence	SYNE1 ZNF804A TIAM2 FRMD4A	2.80e-03	115	149	4	C0038580
Disease	Substance Use Disorders	SYNE1 ZNF804A TIAM2 FRMD4A	2.80e-03	115	149	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	SYNE1 ZNF804A TIAM2 FRMD4A	2.80e-03	115	149	4	C0029231
Disease	Substance abuse problem	SYNE1 ZNF804A TIAM2 FRMD4A	2.89e-03	116	149	4	C0740858
Disease	congenital myasthenic syndrome (implicated_via_orthology)	CHRNA3 CHRNB2	2.90e-03	16	149	2	DOID:3635 (implicated_via_orthology)
Disease	sphingomyelin measurement	TDRD15 C6orf89 CYP27B1 TM6SF2 TMBIM6 ABCA6	2.96e-03	278	149	6	EFO_0010118
Disease	total lipids in large LDL	TDRD15 TM6SF2 ABCA6	3.02e-03	57	149	3	EFO_0022163
Disease	cholesterol in large LDL measurement	TDRD15 TM6SF2 ABCA6	3.02e-03	57	149	3	EFO_0021901
Disease	cholesterol in IDL measurement	TDRD15 TM6SF2 ABCA6	3.18e-03	58	149	3	EFO_0021899
Disease	phospholipids in LDL measurement	TDRD15 TM6SF2 ABCA6	3.18e-03	58	149	3	EFO_0022294
Disease	alcohol use disorder (implicated_via_orthology)	NPY5R CHRNA3 CHRNB2 RYR2 KDM6A	3.18e-03	195	149	5	DOID:1574 (implicated_via_orthology)
Disease	phospholipids in small LDL measurement	TDRD15 TM6SF2 ABCA6	3.34e-03	59	149	3	EFO_0022297
Disease	total lipids in IDL	TDRD15 TM6SF2 ABCA6	3.50e-03	60	149	3	EFO_0022161
Disease	schizophrenia, sex interaction measurement	C6orf89 ABCA6 KAZN	3.50e-03	60	149	3	EFO_0008343, MONDO_0005090
Disease	free cholesterol in IDL measurement	TDRD15 TM6SF2 ABCA6	3.67e-03	61	149	3	EFO_0022181
Disease	sphingosine 1-phosphate measurement	DMD KDM6A	3.67e-03	18	149	2	EFO_0800185
Disease	uric acid measurement	PDE1A C6orf89 TMC6 SLC17A4 BIRC6 F5 ABCA6 LRP2 ADGRL2	3.93e-03	610	149	9	EFO_0004761
Disease	Malignant Neoplasms	ATR BIRC6 MTOR KDM6A	4.10e-03	128	149	4	C0006826
Disease	Cardiomyopathies	ACTN2 RYR2 CS DMD	4.34e-03	130	149	4	C0878544
Disease	Global developmental delay	CHD3 FCSK RHOBTB2 STAG2	4.70e-03	133	149	4	C0557874
Disease	creatinine measurement	PDE1A TMC6 PKD1L3 TM6SF2 BIRC6 SBNO2 FAM83B HOXA13 CSPG4 LRP2 ADGRL2 TDRD12	4.72e-03	995	149	12	EFO_0004518

Protein segments in the cluster

Peptide	Gene	Start	Entry
VLVVPIDGSHWLSMR	UGT1A3	31	P35503
EWAHATIIPKVLAMS	PPP2R1A	476	P30153
LELWTMVHFLVPGIS	EP400	1256	Q96L91
TMEHIRVGWELLLTT	ACTN2	716	P35609
HRRTEGVLDIPMISW	BIRC6	2156	Q9NR09
RATVWMLRLEPLHTQ	CSPG4	781	Q6UVK1
HTMPSWVKTVFLNLL	CHRNA3	336	P32297
EFIHRPSMQDLLWVT	ABCA4	286	P78363
TLLPVWKMIASHRFS	BRD8	1111	Q9H0E9
DTIHISWKLALPMTA	FLRT3	421	Q9NZU0
EIDTTMRWKLLPHSD	ABCA6	1601	Q8N139
ITVHQISPEEMHRIW	B3GALT1	301	Q9Y5Z6
LTTRKMIHEGPLTWR	ARHGEF11	961	O15085
LILWSLLPGHTMETQ	ARHGEF11	1211	O15085
LLRPEALESWKHMNS	ADGRL2	616	O95490
VLLLRMSPQHLTSLW	DOP1A	2226	Q5JWR5
PKWISIMTERSVPHL	ANXA2	211	P07355
TTLNLMLLHWPVTST	ANKRD61	111	A6NGH8
SWALLHLTMVKLALH	DMXL2	2506	Q8TDJ6
VSTVLTLMVPWHSLD	SLC7A4	286	O43246
SMVWLPVLHRVAAAE	DMD	3291	P11532
TTLHSMWLSFPLIHR	ALG14	121	Q96F25
PKWISIMTERSVPHL	ANXA2P2	211	A6NMY6
SHWMVALLLLLSAEP	CD79B	11	P40259
VMHLREWPALLVSST	ALG1L	16	Q6GMV1
LPPKVWHSEMTVSVT	IQCG	11	Q9H095
HWDMSLPLIVTLSTI	PCDH17	701	O14917
DLFMHRKSDVLTTPW	JAK1	676	P23458
LETLFHTWMVPAVRV	LARGE2	141	Q8N3Y3
RTSLELWMHTDPVSQ	NCSTN	371	Q92542
SLLLTHVPLSWLSMR	KCNK6	146	Q9Y257
TIPWDAVEKMVSLHT	LRFN5	161	Q96NI6
STLLTMAMPHWLRHL	CYP27B1	231	O15528
LLALSWVVSILHTML	OR1B1	146	Q8NGR6
MVEKRVLSLAWEHPF	PRKCQ	426	Q04759
VIHLTRSVQLWPAME	MDN1	2921	Q9NU22
ELVRTTPMSHWKAGT	KAZN	436	Q674X7
STLISIPHSLLWKMF	KCTD16	41	Q68DU8
KHHMVTTPTLLLWGE	EPHX4	291	Q8IUS5
HLVSTEWPRSTRMLL	CYP26B1	111	Q9NR63
QHLTSLWPIMVSELI	DOP1B	2086	Q9Y3R5
LQSVKSIVPMVHLSW	KDM6A	1261	O15550
RVITSHWAEDMKPLL	DDX60	331	Q8IY21
MPTLEHTTKSFLRNW	FAM83B	481	Q5T0W9
TLILHYSISMPVWED	FLNB	116	O75369
SSHQDNLWPMILTLL	ITGA3	741	P26006
PIIAVSMIHRFWKSA	OR51I1	256	Q9H343
LHTGIMHWLTELEIL	PDE1A	236	P54750
VPAAKTRHTASAWLM	PGLYRP2	41	Q96PD5
MPEVSVLVLSRHSWP	CUL7	1386	Q14999
LAMHSWVLPSADLAA	RASGRP4	86	Q8TDF6
LSLASEIMLLPQWIH	DNAH12	451	Q6ZR08
IAMLLKTDQPTRHWI	DNAH12	3066	Q6ZR08
PHTMSRSQKFLIWLS	GDPD1	241	Q8N9F7
IMRAWSDGSHLLPVI	LRP2	851	P98164
TLPSMVHLIQEGWRT	HAUS5	286	O94927
HLAEVWRMLSVELPS	MROH8	436	Q9H579
MAWTPLLLSLLAHCT	IGLV3-12	1	A0A075B6K2
IMATIWIEHRLHTPM	OR10H4	46	Q8NGA5
VSQMATLLARKHRPW	HHAT	81	Q5VTY9
TSHLELVESIWTYMP	FBXO38	146	Q6PIJ6
ISKAHVPSWKMTLLN	NTS	46	P30990
HDMLPIWFTTSLDTL	NLGN4Y	121	Q8NFZ3
TSDVLHSAWILILHM	FCSK	81	Q8N0W3
PALIKSIWAMAISQH	FRMD4A	301	Q9P2Q2
SLRMTPDQALKHAWI	DYRK4	386	Q9NR20
MSVLKTFLHDPLVEW	ATR	2551	Q13535
SPWVAAILPHVISRM	HTT	3066	P42858
KWMQTIPFVLSASLH	CPZ	366	Q66K79
HAWDRSLSVHPLSML	DOCK5	1536	Q9H7D0
SWIEFITERHPDMLT	CPB2	131	Q96IY4
IHSTMIGKIWLTILF	GJA9	16	P57773
IKPEWMTVHRIINHS	CHD3	626	Q12873
DVSATKIPHIWLMLS	FNDC11	191	Q9BVV2
VLMVLHSPSLLASWQ	DIPK2A	26	Q8NDZ4
WAKRAALPSHVVTML	CS	141	O75390
WCSDLHLLDMLTPTE	ITSN1	1221	Q15811
PTMLAVLDLWHTNFK	DNAH7	276	Q8WXX0
MSAVVCLWLRHLPSL	FANCC	236	Q00597
ILMIWLMATPHSHET	TMBIM6	66	P55061
HLLTLASWGPEMVLL	MAN2B1	901	O00754
MAAAPALKHWRTTLE	MAN2C1	1	Q9NTJ4
TLDMASHTWLALAPL	KLHDC8B	51	Q8IXV7
LLTHVPMWSARLLTC	CRIPAK	96	Q8N1N5
VPMWSARLLTRAHVE	CRIPAK	346	Q8N1N5
ILEMWNLHPSTLTLT	IL21R	36	Q9HBE5
TLRIWDLSPSHCMLA	EML5	1021	Q05BV3
TWRSLIHHIRLMSLP	C6orf89	96	Q6UWU4
AASAPEMLIQHSLWR	FAM216A	186	Q8WUB2
SSQLFWEPMKVHDIR	GPX6	166	P59796
ILVSLPWVRSSHSMT	SLC17A4	381	Q9Y2C5
VHMTLELPWSADRAI	SBNO1	961	A3KN83
PTVAKWSRLIHMSIV	SLC38A11	191	Q08AI6
LHVQFLSHVLWSRMP	RYR2	1586	Q92736
ERSLLHDMLPIWFTA	NLGN4X	116	Q8N0W4
PQSMVWLAVLHRVTI	DRP2	586	Q13474
SWVKIMTRAHEVPSV	DNAH5	1661	Q8TE73
VMPVDWKSSHTRTLH	FEZ2	101	Q9UHY8
LSWVLTTFHAMLHTL	OR1E2	156	P47887
WLLPLTIMASQRHLS	MT-ND4	71	P03905
WVLTNCPALMHTLLL	OR1N2	166	Q8NGR9
RAIIAITPLSWMVSH	OR52I2	181	Q8NH67
VTILFIIWMDPSLHQ	OR52L1	61	Q8NGH7
VTILFIIWMDPSLHQ	OR52L2P	61	Q8NGH6
SLVVSPHEDMRTWLK	MTOR	1641	P42345
LNIPMRAALSHSLWE	GARIN1A	271	Q6NXP2
IMHLAPWTTRLSCSL	RSPH6A	601	Q9H0K4
SAMLAIHSNKPALWI	UTP6	131	Q9NYH9
LLTRLAQHMKWPSVS	RGL2	566	O15211
PVLITASEDHTLKMW	STRN	476	O43815
PSRHAISEVMSWISL	SYNE1	6911	Q8NF91
IKWTPELENLTAHMT	TDRD15	261	B5MCY1
WIISSLTPKHLQAGM	F5	306	P12259
MAWSPLFLTLITHCA	IGLV1-36	1	A0A0B4J1U3
MAWSPLLLTLLAHCT	IGLV1-40	1	P01703
APEFLIHPTVWLTTM	ABCC6	101	O95255
KSLESWLTHAMVNIP	RFX1	716	P22670
TVWIDPMVHITNLSS	TDRD12	1041	Q587J7
TILILVFAVSWMPLH	NPY5R	371	Q15761
MESRMWPALLLSHLL	PIANP	1	Q8IYJ0
HISIASLPGMWERTL	KYAT1	226	Q16773
PDHTEKLTMWRLADI	MTR	1181	Q99707
ISAHKPLLISSCDWM	RHOBTB2	511	Q9BYZ6
MLWRNVSLETHPTSL	PKD1L3	511	Q7Z443
PLWRMTDVVAAFLAH	RNF26	176	Q9BY78
WIRSPRHCLIKSAMT	TEX49	101	A0A1B0GTD5
VHMTLELPWSADRAI	SBNO2	821	Q9Y2G9
NTTLLMTIWLEASLH	OR56A3	46	Q8NH54
FVTWLIGVMTSLLHI	OR7D2	146	Q96RA2
WLDTLSVPLSMARIS	SNTG2	216	Q9NY99
MTASVLLHPRWIEPT	HOXA13	1	P31271
LINLMVDTLHSSTLW	PIGW	461	Q7Z7B1
PTTHTMAPWVKVVFL	CHRNB2	326	P17787
IVPWHTSMQVADRVL	ABHD10	251	Q9NUJ1
LVPKTHLMSESEWRN	CKS1B	31	P61024
HLSPWISMLPTDATL	TICRR	271	Q7Z2Z1
IQETWTVTLEPLAMH	TICRR	316	Q7Z2Z1
LLMHSTVSWLNPFLS	TIAM2	1326	Q8IVF5
ETSWFPSILTAVLHM	SLC16A5	51	O15375
CHSTVTVPKMLRDVW	OR4E1	76	P0C645
SMWLSREQTLHTPVM	STAG2	1101	Q8N3U4
TRLWKAIHTAPVATM	TBL3	101	Q12788
PWKSARLMVHTVATF	SPTAN1	1191	Q13813
TDCTLWTPFNKMHIL	TBC1D9	311	Q6ZT07
TISTLHWSPRVKDLI	GEMIN5	111	Q8TEQ6
WAPHVLMNASVLLLV	VN1R1	176	Q9GZP7
VSPFAMLHSVWSLIP	USP49	376	Q70CQ1
LLSSSMDKTVRLWHI	WDR44	621	Q5JSH3
HWPDMLIELDTLSKQ	XPO5	131	Q9HAV4
SPVMEFWEHRVLAIS	SLC6A11	201	P48066
TLWEMMTLSIPHINL	PBK	236	Q96KB5
MTLKWTSVLLLIHLS	UGT2B11	1	O75310
PVWLENHTALTVVMA	GART	326	P22102
HMTWSVKLDEHIIPL	TPGS2	76	Q68CL5
LSEVLWTMVIHIGLS	ATP6V0A1	751	Q93050
WTMVIHIGLSVKSLA	ATP6V0A1	756	Q93050
VHIWDLRMVTPAVSH	WDR38	171	Q5JTN6
RPWLASHMSTVFLTL	TMC6	641	Q7Z403
MWHPTLIAEALFAIS	TRPC5	471	Q9UL62
KMTSRHWCAVPILFL	TARBP1	476	Q13395
HVSALSHPLWVALMS	TM6SF2	26	Q9BZW4
SHPLWVALMSALILG	TM6SF2	31	Q9BZW4
TIQWCPVLSKSHMLL	WDR25	251	Q64LD2
MHPSSRWSELDLLIL	PIGG	541	Q5H8A4
IWKPLRHDAAEITVM	PIGG	831	Q5H8A4
WLPIHTVETIMISVI	UBE2G1	111	P62253
HARLPVKWMALESLQ	MST1R	1246	Q04912
VVTVETDHPLLWTMA	TPK1	226	Q9H3S4
TLEIHWLSIINSMVL	TM9SF1	231	O15321
KHRSTVLQWPSEMLV	ZNF804A	431	Q7Z570
TLTASEMLPLLDHWN	N4BP2	1471	Q86UW6
LRWLIMEKDHSSVPS	NAPEPLD	81	Q6IQ20